Page 510«..1020..509510511512..520530..»

Siemens, UI Healthcare to Enhance Medical Imaging Technology – HITInfrastructure.com

Posted: Published on November 12th, 2020

Source: Thinkstock November 10, 2020 -Siemens Healthineers and University of Iowa Health Care (UI Healthcare) recently established a ten-year Value Partnership to provide Iowans with access to cutting-edge medical imaging technology. The partnership will also leverage artificial intelligence and data analytics to improve performance and efficiency of medical imaging, expand research opportunities, and invest in workforce training and development for staff and students. Medical technology is changing fast. Continue reading →

Posted in Medical Technology | Comments Off on Siemens, UI Healthcare to Enhance Medical Imaging Technology – HITInfrastructure.com

MAX Automation : with robust business development in the nine-month 2020 period – Marketscreener.com

Posted: Published on November 12th, 2020

PRESS RELEASE MAX Automation with robust business development in the nine-month 2020 period - Order intake affected by corona crisis and down 24.7% y-o-y at Group level to mEUR 210.8 - Group sales decreased by 24.2% y-o-y to mEUR 225.1 - Group EBITDA improved to mEUR 7.3 (9M 2019: mEUR -4.6) Dusseldorf, 12 November 2020 - In the nine-month 2020 period, MAX Automation SE (ISIN DE000A2DA58), listed in the Prime Standard of the Frankfurt Stock Exchange, held its ground well overall despite the COVID-19-related economic crisis. The systematic processing of issues from non-core business led to lower charges at Group level compared with the previous year and an overall improvement in the earnings situation Continue reading →

Posted in Medical Technology | Comments Off on MAX Automation : with robust business development in the nine-month 2020 period – Marketscreener.com

The Technological Revolution in Sterile Processing – Medical Tech Outlook

Posted: Published on November 12th, 2020

In the past, Sterile Processing Departments (SPD) processed simple instruments using relatively simple technology and techniques. Continue reading →

Posted in Medical Technology | Comments Off on The Technological Revolution in Sterile Processing – Medical Tech Outlook

Medical Bed Head Unit Market Demand, Competition, Trends, Industry Analysis by Players and Global Forecasts to 2025 – The Think Curiouser

Posted: Published on November 12th, 2020

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Medical Bed Head Unit market based on product and application Continue reading →

Posted in Medical Technology | Comments Off on Medical Bed Head Unit Market Demand, Competition, Trends, Industry Analysis by Players and Global Forecasts to 2025 – The Think Curiouser

Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis – 2 Minute Medicine

Posted: Published on November 12th, 2020

1. Short-term indigo naturalis therapy demonstrated symptomatic improvement in patients with mild to moderate ulcerative colitis. Evidence Rating Level: 1 (Excellent) Treatment options for ulcerative colitis (UC), an inflammatory bowel disease affecting the colon and rectum, are diverse, with the addition of biologics to conventional treatment in recent years Continue reading →

Posted in Ulcerative Colitis | Comments Off on Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis – 2 Minute Medicine

Seres Therapeutics Announces Initiation of Phase 1b Trial of SER-301 for the Treatment of Ulcerative Colitis – Business Wire

Posted: Published on November 12th, 2020

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced that it has dosed the first patient in its Phase 1b trial evaluating SER-301 for the treatment of active mild-to-moderate ulcerative colitis (UC). SER-301 is an oral, rationally-designed microbiome therapeutic designed to dampen the aberrant gastrointestinal inflammation central to ulcerative colitis and induce clinical remission in patients suffering from active UC Continue reading →

Posted in Ulcerative Colitis | Comments Off on Seres Therapeutics Announces Initiation of Phase 1b Trial of SER-301 for the Treatment of Ulcerative Colitis – Business Wire

Ulcerative Colitis Treatment Market 2020 Research by Size, Business Opportunities, Top Manufacture, Industry Growth, Industry Share Report, Regional…

Posted: Published on November 12th, 2020

Global Ulcerative Colitis Treatment Market Size, Growth, Industry Analysis and Forecast 2020 To 2026 Market Overview RnM newly added a research report on the Ulcerative Colitis Treatment market, which represents a study for the period from 2020 to 2026. Continue reading →

Posted in Ulcerative Colitis | Comments Off on Ulcerative Colitis Treatment Market 2020 Research by Size, Business Opportunities, Top Manufacture, Industry Growth, Industry Share Report, Regional…

Ulcerative Colitis Drug Market analyzes the impact followed by restraints and opportunities and projected developments (2020-2027), By Reports And…

Posted: Published on November 12th, 2020

Ulcerative Colitis Drug Market Overview: Reports and Data has recently published a new research study titled Global Ulcerative Colitis Drug Market that offers accurate insights for the Ulcerative Colitis Drug market formulated with extensive research. Continue reading →

Posted in Ulcerative Colitis | Comments Off on Ulcerative Colitis Drug Market analyzes the impact followed by restraints and opportunities and projected developments (2020-2027), By Reports And…

Protagonist Therapeutics to Participate in the Jefferies Virtual 2020 London Healthcare Conference – WFMZ Allentown

Posted: Published on November 12th, 2020

NEWARK, Calif., Nov. 11, 2020 /PRNewswire/ --Protagonist Therapeutics, Inc Continue reading →

Posted in Ulcerative Colitis | Comments Off on Protagonist Therapeutics to Participate in the Jefferies Virtual 2020 London Healthcare Conference – WFMZ Allentown

Connect Biopharma Announces Appointment of Karen J. Wilson and Dr. Kleanthis G. Xanthopoulos to Board of Directors – PRNewswire

Posted: Published on November 12th, 2020

SAN DIEGO and TAICANG, SUZHOU, China, Nov. 12, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune and inflammatory diseases, today announced the appointment of Karen J Continue reading →

Posted in Ulcerative Colitis | Comments Off on Connect Biopharma Announces Appointment of Karen J. Wilson and Dr. Kleanthis G. Xanthopoulos to Board of Directors – PRNewswire

Page 510«..1020..509510511512..520530..»